search
Back to results

Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence and Outcomes (Patient Portal)

Primary Purpose

Depression

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ConnectCare
Sponsored by
Carolyn L Turvey
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Depression focused on measuring patient portals, treatment adherence

Eligibility Criteria

18 Years - 89 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • English speaking,
  • PHQ-9 score of 10 or higher (questions 1-8 only),
  • Taking medication for depressive symptoms,
  • 1 or more appointments scheduled or planned with University of Iowa psychiatry provider in next 6 months,
  • Home computer w/internet access,
  • MyChart (University of Iowa Healthcare's patient portal) account/MyChart enrollment

Exclusion Criteria:

  • Psychotic disorder/symptoms,
  • Current substance use disorders (other than alcohol, tobacco, marijuana),
  • Active suicidal ideation within past 1 year,
  • Cognitive impairment

Sites / Locations

  • University of Iowa Carver College of Medicine, Dept. of Psychiatry

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Group 1

Group 2

Arm Description

Outcomes

Primary Outcome Measures

Patient Health Questionnaire (PHQ-9)
measures the severity of depression symptoms

Secondary Outcome Measures

Full Information

First Posted
November 20, 2020
Last Updated
June 9, 2022
Sponsor
Carolyn L Turvey
search

1. Study Identification

Unique Protocol Identification Number
NCT04646681
Brief Title
Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence and Outcomes
Acronym
Patient Portal
Official Title
Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence, Satisfaction, and Outcomes
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
March 31, 2021 (Actual)
Primary Completion Date
April 30, 2022 (Actual)
Study Completion Date
April 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Carolyn L Turvey

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this research study is to learn how best to use patient portals to help improve the treatment of mood disorders.
Detailed Description
This study is being done in 3 phases. First 2 phases were observational with total enrollment of 300 subjects. The final 3rd phase is interventional and we are anticipating to enroll 50 subjects. It is described below. Patients being treated for depressive symptoms at the University of Iowa, Department of Psychiatry are invited to participate. Participants will complete a remote (phone or video) visit. After being informed about the study and potential risks, those who consent to being in the study will be assigned to one of two groups. They will complete an online survey and receive some basic training on patient portals. After the visit. both groups will be followed for 6 months. Depending on their group assignment, they will complete: two to five phone calls with a study team member and two to five online questionnaires

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
patient portals, treatment adherence

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group 1
Arm Type
Experimental
Arm Title
Group 2
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
ConnectCare
Intervention Description
increased monitoring between clinical mental health visits
Primary Outcome Measure Information:
Title
Patient Health Questionnaire (PHQ-9)
Description
measures the severity of depression symptoms
Time Frame
Once per month for 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: English speaking, PHQ-9 score of 10 or higher (questions 1-8 only), Taking medication for depressive symptoms, 1 or more appointments scheduled or planned with University of Iowa psychiatry provider in next 6 months, Home computer w/internet access, MyChart (University of Iowa Healthcare's patient portal) account/MyChart enrollment Exclusion Criteria: Psychotic disorder/symptoms, Current substance use disorders (other than alcohol, tobacco, marijuana), Active suicidal ideation within past 1 year, Cognitive impairment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carolyn Turvey, phD
Organizational Affiliation
University of Iowa
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Iowa Carver College of Medicine, Dept. of Psychiatry
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence and Outcomes

We'll reach out to this number within 24 hrs